life sciences trend analysis 2013
DESCRIPTION
Life Sciences Trend Analysis 2013. FRANCE. About Us. The following statistical information has been obtained from Biotechgate . Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. www.biotechgate.com - PowerPoint PPT PresentationTRANSCRIPT
Life Sciences Trend Analysis 2013
FRANCE
About Us
The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology,Pharmaceutical and Medical Device industries. www.biotechgate.com
The French Biotech Database is a part of the global Biotechgate and is brought to you in partnership with APIM - the Lille Métropole Development Agency; assisting companies to establish and grow thier Business in France from Lille. www.frenchbiotech.com
Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy. www.venturevaluation.com
Status of the Sector
2012 Statistics
France 2013 Statistics
392 Total Biotech Companies 685
91 Biotech - Therapeutics 159
242 Biotech - R&D Services 349
59 Biotech - Other 177
96% Percentage of SME's 94%
6%Percentage of Publicly Owned
Companies4%
USD 24 M (2011)
Financing/Capital RaisedUSD 150 M
(2012)
204 Licensing Opportunities 342
Key Activities of Biotechnology Companies
Historical DataSubsector 201
32012
Environment 4% 1%Contract Research and Manufacturing
15% 19%
Diagnostics and Analytical Services
17% 18%
Genomics and Proteomics 5% 7%Food and Nutraceuticals 4% 3%Other Services and Suppliers 26% 25%Therapeutics 13% 13%Other 16% 14%
2013 Data
Contract Re-
search and
Manu-factur-
ing15%
Diagnostics and Analyt-ical Services
17%
Envi-ronment
4%
Food and Nu-traceu-ticals4%
Ge-nomics
and Pro-teomics
5%
Other Services
and Suppli-
ers26%
Therapeutics13% Other
16%
2013 Data
Company Foundation Timeline
19951996
19971998
19992000
20012002
20032004
20052006
20072008
20092010
20112012
20130
5
10
15
20
25
30
35
1 3 3
10 106 5
116
127
11 10 84 6
2
75
611
9
17
19
10
18
14
13
175
1313
98
5
5
4
6
2
1
3
6
43
3
56
1 1
1
Biotechnology - Therapeutics and DiagnosticsBiotechnology / R&D ServicesBiotechnology - other
Year
No.
of
Com
panie
s F
ounded
Company Ownership
Historical DataSubsector 201
3201
2Private/ Independent
84% 87%
Public 4% 6%Subsidiary 12% 7%
Private / inde-pendent
85%
Public4%
Subsidiary12%
2013 Data
Sources of Company Foundations
Historical DataCompany Foundation 2013 2012Independent foundation 57% 70%Spin-off from company 2% 3%Spin-off from public institution / NPO 4% 9%Spin-off from university 3% 3%Subsidiary 11% 10%Other 4% 4%
Undisclosed18%
Indepen-dent
founda-tion57%
Merger1%
Spin-off from company2%
Spin-off from public institution / NPO
4% Spin-off from
univer-sity3%
Subsidiary11%
Other4%
2013 Data
Number of Employees
Historical DataNo. of Employees 2013 20121-10 32% 26%
11-50 49% 56%
51-200 15% 14%
Greater than 200 4% 6%
1-10:32%
11-50:49%
51-200:15%
201+:4%
2013 No. of Employees
Products in the Pipeline
2013
2012
2013
2012
2013
2012
2013
2012
Pre
clin
ical
Phase
IPhase
II
Phase
III
0 20 40 60 80 100 120 140 160
136
105
53
37
73
58
20
15
No. of Products
Financing Rounds in France & 3 Major Financing Rounds
Financing for 2012/2013 Private Biotech Companies
Major Financings in 2012/2013
SectorUSD M
Magnisense SARL Biotech – R&D 59
Poxel SABiotech – Therapeutics &
Diagnostics17
TxCellBiotech – Therapeutics &
Diagnostics16
2007 2008 2009 2010 2011 20120
50
100
150
200
0
5
10
15
20
Financing ValueNumber of Financings
Half Yearly
Fin
an
cin
g V
alu
e
US
D M
Nu
mb
er
of
Fu
nd
ing
R
ou
nd
s
About Biotechgate
Biotechgate contains over 29’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data.
To register for free or learn more about the different subscription options, please visit www.biotechgate.com.
Terms of Use
The “French Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at www.biotechgate.com. The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof.
The use of the figures and graphs provided in this report is free of charge for any presentations as long as www.biotechgate.com is clearly cited as the source. For all other uses please contact us for terms and conditions.
Biotechgatec/o Venture Valuation VV AGKasernenstrasse 11 +41 (43) 321 86 608004 Zurich [email protected] www.venturevaluation.com